CEPA Animal Testing Canada: Understanding ECCC’s Strategy and Canada’s Commitment to Replacing Animal Testing

Canada is undergoing a significant transformation in how chemical safety is evaluated. Long reliant on vertebrate animal testing, regulatory frameworks are now actively shifting toward humane, science-driven alternatives. This blog explores the broader policy landscape under the Canadian Environmental Protection Act, 1999 (CEPA), the role of Environment and Climate Change Canada (ECCC), and Canada’s formal commitment to the 3Rs—Replace, Reduce, and Refine animal testing. It also outlines Dell Tech’s position in supporting this transition through validated non-animal methods, including our Corrositex® service.  

For decades, vertebrate animal testing has served as the foundation of chemical hazard and risk assessment. Traditional toxicity testing has relied on animal models, which have scientific and regulatory limitations. Data from acute toxicity, irritation, corrosion, and systemic toxicity studies in animals have traditionally been regarded as the regulatory “gold standard.” While these methods laid the groundwork for chemical safety decisions, they also raised ongoing ethical, scientific, and economic concerns. 

Globally, momentum is growing for animal-free science. Progress in toxicology, computational modelling, in vitro assays, and understanding biological pathways has shown that many regulatory questions can be addressed without using animals—often more efficiently and with greater relevance to humans. The ethical concerns are heightened by the animal suffering caused by these tests, including pain, distress, and death. Regions such as the European Union, the United States, and now Canada are incorporating these advances into policies and laws. Other countries are advancing rapidly in adopting alternative methods, and Canada is working to catch up with these global standards. 

Canada’s evolving approach signals not just regulatory modernization, but a values-based commitment to humane science. 

CEPA and ECCC’s Mandate  

The Canadian Environmental Protection Act, 1999 (CEPA) is the cornerstone of Canada’s federal chemicals management framework. CEPA provides the legal authority to assess, manage, and control substances that may pose risks to human health or the environment. Risk assessments are a central part of this process, determining the safety of chemicals and other substances. 

Under CEPA, ECCC, in collaboration with Health Canada, is responsible for: 

• Assessing new and existing substances 

• Identifying toxic or potentially toxic chemicals 

• Implementing risk management measures 

• Ensuring science-based, transparent decision-making 

CEPA matters because it governs how data are generated, interpreted, and applied in regulatory decisions. Historically, this often meant requiring animal test data. However, as science evolves, CEPA has proven flexible enough to incorporate new approach methodologies (NAMs) and alternative testing strategies. CEPA regulatory programs are increasingly focused on integrating NAMs to replace or reduce animal-based toxicity testing. 

This adaptability has become central to Canada’s modernization of chemical risk assessment, including the development and validation of alternative approaches to traditional toxicity testing. 

ECCC’s 3Rs Strategy 

ECCC’s formal adoption of the 3Rs framework aligns Canada with internationally recognized best practices in ethical science. 

Replace: Shift to Non-Animal Methods  

Replacement is the primary goal. Where scientifically valid alternatives exist, ECCC is committed to prioritizing non-animal test methods, including: 

• In vitro assays 

• Computational and predictive toxicology 

• Weight-of-evidence and read-across approaches 

ECCC is committed to policies that replace animal testing wherever possible, supporting the development and adoption of modern, non-animal methods. 

Methods such as reconstructed human tissue models and chemical reactivity assays are increasingly accepted for endpoints like skin corrosion and irritation. 

Reduce: Minimize Animal Use 

When replacement is not yet feasible, ECCC aims to reduce the number of animals used by: 

• Avoiding duplicative testing 

• Encouraging data sharing and use of existing information 

• Applying integrated testing strategies that limit animal studies 

Strategies to reduce animal testing in regulatory submissions are essential to meet CEPA commitments and advance ethical science. 

The development and validation of new methods, including next-generation approaches, are a key part of this transition. 

Validated alternative methods can facilitate regulatory approval by providing reliable data for decision-making. 

Refine: Improve Animal Welfare  

For testing that remains unavoidable, refinement ensures that: 

• Pain and distress are minimized. Improved animal care standards are essential to reducing suffering in scientific research. Refinement efforts specifically aim to prevent severe pain, such as that experienced in Category E toxicity tests, which can cause death, extreme distress, and suffering. 

• Study designs are optimized 

• Humane endpoints are applied 

Subjecting animals to unnecessary procedures is increasingly being replaced by more humane approaches. 

Together, these principles reflect a structured, science-based path away from routine animal testing. Ongoing efforts to refine vertebrate animal testing are central to Canada’s ethical science policies. 

Legislative Drivers and Policy Direction  

A major milestone came with the 2023 updates to CEPA, which explicitly strengthened provisions on replacing animal testing. These changes were enacted through the Budget Implementation Act, which included key amendments to environmental and health protection policies. The legislative process culminated in royal assent, formally enacting the new provisions. These amendments formalized the government’s obligation to promote and prioritize alternatives wherever scientifically possible. 

In July 2023, a notice published in the Canada Gazette further clarified ECCC’s expectations and policy direction. Key implications included: 

• A clear signal to industry that non-animal data are not only acceptable, but encouraged 

• Increased regulatory confidence in validated alternative methods 

• Greater transparency around how animal testing decisions are made 

This policy direction reduces uncertainty for regulated parties and accelerates the adoption of humane, innovative science. Related legislative frameworks, such as the Drugs Act, also address the reduction of animal testing in chemical safety assessments. Recent efforts to ban or minimize cosmetic animal testing in Canada further demonstrate the broader shift toward alternative methods. 

Stakeholder Engagement  

ECCC’s strategy was informed by extensive stakeholder consultation, including industry, non-governmental organizations, academics, and the public. The resulting “What We Heard” summaries revealed strong alignment across sectors. A draft strategy was circulated for feedback to guide the implementation of new approach methods, ensuring stakeholder input shaped the process. 

Key themes included: 

• Broad support for reducing and ultimately eliminating animal testing 

• Recognition that NAMs can improve efficiency and relevance 

• Calls for clear regulatory guidance and acceptance criteria 

Industry stakeholders emphasized the need for predictable, science-based pathways to regulatory acceptance of alternative data. They also noted that clear criteria for regulatory decision making are essential for the acceptance of alternative data. Public respondents underscored ethical considerations and Canada’s responsibility to lead. 

This convergence of views has helped create a stable foundation for implementation. 

Dell Tech’s Role in Supporting Canada’s Transition  

At Dell Tech, we actively support Canada’s transition toward animal-free chemical safety assessment. As a testing laboratory serving regulated industries, we recognize both the ethical imperative and the regulatory momentum behind non-animal methods. We are committed to adopting cutting edge technologies for chemical safety assessment, ensuring our clients benefit from the most advanced and innovative approaches available. 

These advanced methods serve important scientific purposes by promoting humane, effective, and ethical alternatives to traditional animal testing. 

Corrositex® and Ocular Irritection Assey®: A Proven Non-Animal Alternative  

Corrositex® and Ocular Irritection Assey® are internationally recognized, validated in vitro test methods for assessing skin corrosion and eye irritation. It replaces traditional animal-based corrosion and irritation studies by measuring chemical reactivity through a synthetic membrane system.  

Key advantages include:  

• No animal use  

• Rapid turnaround times  

• Regulatory acceptance under OECD guidelines  

• Alignment with CEPA and ECCC’s replacement objectives  

Alignment with Federal Strategy  

By offering Corrositex® and Ocular Irritection Assey® testing, Dell Tech enables clients to: 

• Meet regulatory requirements under CEPA 

• Reduce reliance on animal testing 

• Demonstrate proactive compliance with ECCC’s 3Rs strategy 

• Support corporate sustainability and ethical commitments 

There is an urgent need for Canada to invest in a national centre dedicated to non-animal research methods. Establishing and funding such a centre is essential to ensure continued progress in humane, modern science and to keep Canada globally competitive. Dedicated funding for this national centre would help advance innovative alternatives and prevent setbacks in the transition away from animal testing. 

Dell Tech views alternative methods not as a future aspiration, but as a current operational standard. 

Explore Corrositex® and Irritection®: Cruelty-Free Corrosion to Skin and Eye Irritation Testing)) 

Climate Change and Environmental Protection: Broader Impacts of Reducing Animal Testing 

The shift away from animal testing under the Canadian Environmental Protection Act (CEPA) is not only a win for animal welfare, but also a significant step forward for climate change mitigation and environmental protection in Canada. By embracing non-animal methods—such as in vitro assays and advanced computer modeling—Canada is reducing the environmental footprint associated with traditional vertebrate animal testing. These alternative methods require fewer resources, less energy, and generate less waste, all of which contribute to lower greenhouse gas emissions and a more sustainable approach to chemical safety. 

The refinement and replacement of vertebrate animal testing also align with the goals of the Strengthening Environmental Protection for a Healthier Canada Act, which amended CEPA to emphasize environmental justice and intergenerational equity. This means that Canada is not only protecting animals, but also ensuring a healthier environment and safeguarding human health for current and future generations. By prioritizing scientifically justified alternative methods, Canada is supporting sustainable development and reinforcing its commitment to a cleaner, safer environment. Reducing reliance on animal testing is a crucial part of Canada’s broader strategy to address climate change and promote environmental stewardship. 

Public Support and Investment in Alternatives 

Public sentiment in Canada is increasingly in favor of reducing animal testing and accelerating the adoption of non-animal methods. According to a recent survey by the Montreal SPCA, a clear majority of Canadians support the use of alternative methods in research and regulatory testing, reflecting growing awareness of both ethical concerns and scientific advancements. This groundswell of support is matched by action at the federal level, with the Canadian government investing in the development of new approach methods (NAMs) and establishing initiatives like the Canadian Centre for Alternatives to Animal Methods (CCAAM) at the University of Windsor. 

However, to fully realize the potential of these alternative methods, sustained and dedicated funding is essential. Continued investment will drive the development, validation, and regulatory acceptance of innovative testing strategies, ensuring that Canada remains at the forefront of scientific research and regulatory testing. A clear implementation framework is also needed to guide the transition, support industry adoption, and maintain public trust. With strong public backing and government commitment, Canada is well-positioned to lead in the development and use of non-animal methods for safer, more ethical research and testing. 

A Future Without Animal Testing  

Canada is positioning itself as a global leader in humane, modern chemical regulation. Through CEPA, ECCC’s 3Rs strategy, and recent legislative updates, the federal government has made clear that animal testing should no longer be the default. The commitment to replace, reduce or refine animal testing is now a guiding principle in Canadian chemical regulation. 

For the industry, this shift represents both responsibility and opportunity: 

• Responsibility to adopt scientifically sound, ethical practices 

• Opportunity to innovate, streamline testing, and align with public expectations 

There is a strong regulatory focus on reducing the use of vertebrate animals in chemical safety assessments. These efforts are aimed at protecting human health, ensuring a healthy environment, and minimizing exposure to hazardous substances. 

Dell Tech is proud to support this transition by providing validated non-animal testing solutions that meet regulatory needs today. 

As Canada moves toward a future without animal testing, collaboration between regulators, industry, and laboratories will be essential. It will also be important to consider vulnerable environments in future risk assessments and regulatory decisions. 

Next Steps and Call to Action 

Achieving a future where animal testing is replaced by non-animal methods in Canada will require coordinated action from all sectors—government, industry, and the public. The next phase involves putting the CEPA strategy into practice by identifying and prioritizing new approach methods, advancing research and data generation, and fostering collaboration across regulatory and scientific communities. Canadians can play a vital role by supporting the official federal government petition advocating for a transition to animal-free research and testing, and by reaching out to their Members of Parliament to call for dedicated funding and a robust implementation framework for alternative methods. 

Raising awareness through social media and community engagement can further amplify the message and encourage broader participation. By working together, Canada can become a world leader in the adoption of non-animal methods, setting a global standard for humane, sustainable, and scientifically advanced research and testing. Now is the time for collective action—to ensure that animal testing becomes a practice of the past, and that innovative, ethical alternatives define the future of Canadian science.